Celyad Oncology SA
F:1C0S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
F:1C0S
|
BE |
|
S
|
Sopra Steria Group SA
F:OR8
|
FR |
|
F
|
Fortune Brands Innovations Inc
SWB:2FB
|
US |
|
B
|
Berry Global Group Inc
F:BP0
|
US |
|
Askoll Eva SpA
MIL:EVA
|
IT |
|
V
|
ViacomCBS Inc
F:0VV
|
US |
|
Boot Barn Holdings Inc
NYSE:BOOT
|
US |
|
U
|
Urban Outfitters Inc
F:UOF
|
US |
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
G
|
Global Payments Inc
F:GLO
|
US |
|
R
|
Renault SA
XBER:RNL
|
FR |
|
T
|
Tivity Health Inc
F:AFN
|
US |
|
F
|
Federated Hermes Inc
DUS:3KC
|
US |
|
Proact IT Group AB
F:PIU0
|
SE |
|
M
|
Murphy Oil Corp
F:MUQ
|
US |
|
A
|
Amgen Inc
SWB:AMG
|
US |
|
Lenzing AG
F:LEN
|
AT |
|
M
|
MacroGenics Inc
F:M55
|
US |
|
ANTA Sports Products Ltd
F:AS7
|
CN |
|
SKF AB
F:SKFA
|
SE |
|
F
|
Foot Locker Inc
F:WOO
|
US |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
N
|
NP3 Fastigheter AB
F:N33
|
SE |
|
S
|
Sumitomo Realty & Development Co Ltd
XBER:RL2
|
JP |
Dividends
Dividend Yield
Celyad Oncology SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Celyad Oncology SA
1C0S have decreased by 0%.
Payout Ratio
Celyad Oncology SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 1C0S is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1C0S Price
Celyad Oncology SA
| Average Annual Return | -27.36% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -99% |
| Market Capitalization | 11m EUR |
| Shares Outstanding | 22 594 000 |
| Percentage of Shares Shorted |
N/A
|
